Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Crinetics Pharmaceuticals, Inc.Listing on record | Other | $1.4M | SEC | ||
Crinetics Pharmaceuticals, Inc.Listing on record | OtherD (derivative) | $478K | SEC | ||
Crinetics Pharmaceuticals, Inc.Listing on record | Other | $503.6K | SEC | ||
Crinetics Pharmaceuticals, Inc.Listing on record | OtherD (derivative) | $503.6K | SEC | ||
Crinetics Pharmaceuticals, Inc.Listing on record | OtherD (derivative) | $1.1M | SEC | ||
Crinetics Pharmaceuticals, Inc.Listing on record | OtherD (derivative) | $545.1K | SEC | ||
Crinetics Pharmaceuticals, Inc.Listing on record | OtherD (derivative) | $1.1M | SEC | ||
Crinetics Pharmaceuticals, Inc.Listing on record | OtherD (derivative) | $1.2M | SEC | ||
Crinetics Pharmaceuticals, Inc.Listing on record | OtherD (derivative) | $772.1K | SEC | ||
Crinetics Pharmaceuticals, Inc.Listing on record | OtherD (derivative) | $772K | SEC | ||
Crinetics Pharmaceuticals, Inc.Listing on record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Crinetics Pharmaceuticals, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Cullinan Therapeutics, Inc.Listing on record | Buy | $1.4M | conv 19 | SEC | |
Passage BIO, Inc.Listing on record | Buy | $2.3K | conv 32 | SEC | |
Passage BIO, Inc.Listing on record | Buy | $83.2K | conv 30 | SEC | |
Passage BIO, Inc.Listing on record | Buy | $138.3K | conv 30 | SEC | |
Crinetics Pharmaceuticals, Inc.Listing on record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Crinetics Pharmaceuticals, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
TScan Therapeutics, Inc.Listing on record | BuyD (derivative) | $30M | Unusual size | SEC | |
TScan Therapeutics, Inc.Listing on record | Buy | $290K | conv 39 | SEC | |
TScan Therapeutics, Inc.Listing on record | Buy | $95.7K | conv 39 | SEC | |
TScan Therapeutics, Inc.Listing on record | Buy | $4.1K | conv 52First in 12mo | SEC | |
Crinetics Pharmaceuticals, Inc.Listing on record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Crinetics Pharmaceuticals, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Crinetics Pharmaceuticals, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |